Cash Flow - Amylyx Pharmaceuticals, Inc. (AMLX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -123.34 | -167.65 | 11.92 | -179.87 | -74.80 | -36.70 | -10.69 |
| Cash flow from investing | 14.04 | 75.65 | 92.05 | -238.99 | -46.41 | -0.15 | -0.15 |
| Cash flow from financing | 257.03 | 0.35 | 3.54 | 431.79 | 158.51 | 46.82 | 0.67 |
| Change in cash | 147.73 | -91.65 | 107.52 | 12.93 | 37.30 | 9.98 | -10.17 |
Show Quarterly Cash Flow
Cash Flow - Amylyx Pharmaceuticals, Inc. (AMLX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -36.88 | -27.90 | -30.37 | -25.25 | -39.82 | -59.01 | -41.57 | -66.58 | -0.49 | 13.55 | -5.17 | 8.61 | -5.07 | -49.70 | -43.08 | -46.46 | -40.63 | -28.24 | -20.87 | -13.05 | -12.64 | -8.89 |
| Cash flow from investing | 36.26 | 29.47 | 5.24 | 22.99 | -43.66 | 64.98 | 38.82 | -28.96 | 0.82 | 20.93 | -108.09 | 123.22 | 55.99 | -228.18 | 84.04 | 4.46 | -99.31 | 2.81 | -49.21 | 2.81 | -0.01 | -0.15 |
| Cash flow from financing | 3.22 | -0.21 | 191.61 | -0.03 | 65.66 | 0.11 | 0.08 | 0.03 | 0.13 | 0.23 | 0.89 | 1.38 | 1.04 | 232.16 | 199.63 | -0.83 | 200.46 | -1.07 | 131.65 | 1.99 | 25.93 | 1.18 |
| Change in cash | 2.60 | 1.36 | 166.47 | -2.29 | -17.82 | 6.08 | -2.67 | -95.51 | 0.46 | 34.71 | -112.37 | 133.22 | 51.96 | -45.72 | 240.59 | -42.83 | 60.51 | -26.50 | 61.58 | -8.24 | 13.27 | -7.86 |